Tissue leptin levels in patients with breast cancer

被引：0

作者：

Karaduman, M. ^{[1
]}

Bilici, A. ^{[2
]}

Ozet, A. ^{[3
]}

Sengul, A. ^{[4
]}

Musabak, U. ^{[4
]}

Alomeroglu, M. ^{[5
]}

机构：

[1] Etimesgut Mil Hosp, Dept Internal Med, Ankara, Turkey

[2] Dr Lutfi Kirdar Kartal Educ & Res Hosp, Dept Med Oncol, Istanbul, Turkey

[3] Gulhane Mil Med Acad, Dept Med Oncol, Ankara, Turkey

[4] Gulhane Mil Med Acad, Dept Immunol, Ankara, Turkey

[5] Diyarbakir Mil Hosp, Dept Pathol, Diyarbakir, Turkey

来源：

JOURNAL OF BUON | 2010年 / 15卷 / 02期

关键词：

breast cancer; cancer tissue; leptin; normal breast tissue; prognostic factor; MESSENGER-RNA; EXPRESSION; RECEPTOR; OBESE; PLASMA; RISK;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose: High leptin serum levels, overexpression of leptin and its two main receptor isoforms, OBR-L and OBR-S, have been documented in breast cancer patients. In the present study, the relationship between tissue leptin levels and breast cancer was evaluated. Methods: Thirty-three normal breast tissue samples and 33 breast cancer tissue samples from 33 patients with breast cancer were evaluated. The association of tissue leptin levels and important prognostic factors related to breast cancer was analyzed. Results: Mean tissue leptin levels in breast cancer tissue samples (5.02 +/- 1.06 pg/ml) were significantly higher than those found in normal breast tissue (2.02 +/- 0.83 pg/ml; p=0.01). No correlation was found in tissue leptin levels and menopausal status, hormone receptor and HER-2/neu status, lymph node involvement, and histopathologic features. Conclusion: High leptin levels were significantly higher in breast cancer tissue compared with normal tissue. No special correlation was found between tissue leptin levels and different clinicopathological characteristics.

引用

下载

页码：369 / 372

页数：4

共 50 条

[11] Analysis of the expression levels of leptin gene and it's receptor in breast cancer patients
Agnese, V.
Calo, V.
Corsale, S.
Bruno, L.
Augello, C.
Gargano, G.
Gullo, A.
Terrasi, M.
Barbera, F.
La Paglia, L.
Schiro, V.
Calcara, D.
Gregorio, V.
Cascio, S.
Adamo, B.
Morello, V.
Tomasino, R. M.
Bazan, V.
Surmacz, E.
Russo, A.
ANNALS OF ONCOLOGY, 2006, 17 : VII142 - VII142
[12] The serum leptin levels in patients with breast cancer and its relationship with the tumor characteristics
Gumus, Mahmut
Topal, Aslihan
Baloglu, Gulcan
Ozkan, Zeynep
Guler, Senol
Aliustaoglu, Mehmet
Salepci, Taflan
Yayla, Ali
ANNALS OF ONCOLOGY, 2004, 15 : 60 - 60
[13] BRCA1 mutation, leptin and estrogen levels in breast cancer patients
Rzepka-Górska, I
Tarnowski, B
Chudecka-Glaz, A
Górski, B
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2005, 26 (02) : 205 - 206
[14] Urinary tissue factor levels in patients with breast and colorectal cancer
Lwaleed, BA
Chisholm, M
Francis, JL
JOURNAL OF PATHOLOGY, 1999, 187 (03): : 291 - 294
[15] Serum and tissue copper and zinc levels in breast cancer patients
Gupta, SK
Shukla, VK
BRITISH JOURNAL OF CANCER, 1996, 74 : PO14 - PO14
[16] Circulating levels of leptin, adiposity and breast cancer risk
M-H Wu
Y-C Chou
W-Y Chou
G-C Hsu
C-H Chu
C-P Yu
J-C Yu
C-A Sun
British Journal of Cancer, 2009, 100 : 578 - 582
[17] Racial variation of leptin levels in women with breast cancer
Avery, T. P.
Sexton, K. R.
Brewster, A.
El-Zein, R.
Bondy, M.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[18] Circulating levels of leptin, adiposity and breast cancer risk
Wu, M-H
Chou, Y-C
Chou, W-Y
Hsu, G-C
Chu, C-H
Yu, C-P
Yu, J-C
Sun, C-A
BRITISH JOURNAL OF CANCER, 2009, 100 (04) : 578 - 582
[19] Pretreatment plasma leptin and leptin receptor levels in metastatic breast cancer.
Leitzel, K
Demers, L
Ali, SM
Evans, DB
Lipton, A
BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S140 - S140
[20] Antiestrogenic tamoxifen and toremifene increase serum leptin levels in postmenopausal breast cancer patients
Marttunen, MB
Andersson, S
Hietanen, P
Karonen, SL
Koistinen, HA
Koivisto, VA
Tiitinen, A
Ylikorkala, O
MATURITAS, 2000, 35 (02) : 175 - 179

← 1 2 3 4 5 →